C Erce1, R W Parks. 1. Department of Clinical and Surgical Sciences (Surgery), University of Edinburgh, Edinburgh, UK.
Abstract
BACKGROUND: Most patients with liver tumours are not suitable for surgery but interstitial ablative techniques may control disease progression and improve survival rates. METHODS: A review was undertaken using Medline of all reported studies of cryoablation, radiofrequency ablation, microwave ablation, interstitial laser photocoagulation, high-intensity focused ultrasound and ethanol ablation of primary liver tumours and hepatic metastases. RESULTS: Although there are no randomized clinical trials, cryoablation, thermal ablation and ethanol ablation have all been shown to be associated with improved palliation in patients with primary and secondary liver cancer. The techniques can be undertaken safely with minimal morbidity and mortality. CONCLUSION: Although surgical resection remains the first line of treatment for selected patients with primary and secondary liver malignancies, interstitial ablative techniques are promising therapies for patients not suitable for hepatic resection or as an adjunct to liver surgery. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
BACKGROUND: Most patients with liver tumours are not suitable for surgery but interstitial ablative techniques may control disease progression and improve survival rates. METHODS: A review was undertaken using Medline of all reported studies of cryoablation, radiofrequency ablation, microwave ablation, interstitial laser photocoagulation, high-intensity focused ultrasound and ethanol ablation of primary liver tumours and hepatic metastases. RESULTS: Although there are no randomized clinical trials, cryoablation, thermal ablation and ethanol ablation have all been shown to be associated with improved palliation in patients with primary and secondary liver cancer. The techniques can be undertaken safely with minimal morbidity and mortality. CONCLUSION: Although surgical resection remains the first line of treatment for selected patients with primary and secondary liver malignancies, interstitial ablative techniques are promising therapies for patients not suitable for hepatic resection or as an adjunct to liver surgery. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Authors: Y Fellig; I Ariel; P Ohana; P Schachter; I Sinelnikov; T Birman; S Ayesh; T Schneider; N de Groot; A Czerniak; A Hochberg Journal: J Clin Pathol Date: 2005-10 Impact factor: 3.411
Authors: Joerg-Peter Ritz; Kai S Lehmann; Christoph Reissfelder; Thomas Albrecht; Bernd Frericks; Urte Zurbuchen; Heinz J Buhr Journal: Int J Colorectal Dis Date: 2005-05-05 Impact factor: 2.571
Authors: Eli Vlaisavljevich; Joan Greve; Xu Cheng; Kimberly Ives; Jiaqi Shi; Lifang Jin; Alexa Arvidson; Tim Hall; Theodore H Welling; Gabe Owens; William Roberts; Zhen Xu Journal: Ultrasound Med Biol Date: 2016-04-29 Impact factor: 2.998